Danish vaccine maker Bavarian Nordic has appointed Tarja Stenvall, a seasoned executive from pharmaceutical giant Sanofi, as its new CEO—a decisive move to reset leadership and refocus strategy after a failed takeover attempt.

Stenvall brings significant experience from the global pharma landscape, positioning the company to navigate recent setbacks and build momentum in the competitive vaccine market. The appointment signals renewed confidence in the company's direction and its ability to compete on the world stage. Read the full story →

Today's takeaway: Smart leadership transitions can transform setbacks into springboards for growth—and this one could energize the global vaccine industry.